These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Primary in vitro sensitization of murine lymphocytes against isogeneic and allogeneic cells transformed by simian virus 40. Maki T; Howe ML J Immunol; 1976 Oct; 117(4):1398-401. PubMed ID: 62000 [TBL] [Abstract][Full Text] [Related]
23. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor. Howell SB; Dean JH; Law LW Int J Cancer; 1975 Jan; 15(1):152-69. PubMed ID: 236258 [TBL] [Abstract][Full Text] [Related]
24. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes. Ansel S Int J Cancer; 1983 Jun; 31(6):785-90. PubMed ID: 6190766 [TBL] [Abstract][Full Text] [Related]
25. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride. Coggin JH; Gillis LD; Payne WJ J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810 [TBL] [Abstract][Full Text] [Related]
26. [Comparative immunogenicity of irradiated and nonirradiated syngeneic and xenogeneic tumor cells containing a common specific transplantation antigen]. Kliuchareva TE; Kashkina LM; Deĭchman GI Biull Eksp Biol Med; 1978 Aug; 86(8):225-8. PubMed ID: 210867 [TBL] [Abstract][Full Text] [Related]
27. Tumour specific transplantation antigen in hamster tumour cells induced with BK virus. Karjalainen HE; Laaksonen AM; Mäntyjärvi RA J Gen Virol; 1978 Oct; 41(1):171-4. PubMed ID: 212516 [TBL] [Abstract][Full Text] [Related]
28. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein). Tevethia SS; Flyer DC; Tjian R Virology; 1980 Nov; 107(1):13-23. PubMed ID: 6255675 [No Abstract] [Full Text] [Related]
29. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells. Shearer MH; Bright RK; Lanford RE; Kennedy RC Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059 [TBL] [Abstract][Full Text] [Related]
30. Surface proteins of simian-virus-40-transformed cells. Chandrasekaran K; Winterbourne DJ; Luborsky SW; Mora PT Int J Cancer; 1981 Mar; 27(3):397-407. PubMed ID: 6169662 [TBL] [Abstract][Full Text] [Related]
31. Induction of simian virus 40-specific tumour rejection by the Ad2+ND2 hybrid virus. Jay G; Jay FT; Chang C; Levine AS; Friedman RM J Gen Virol; 1979 Aug; 44(2):287-96. PubMed ID: 230283 [TBL] [Abstract][Full Text] [Related]
32. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype. Shearer MH; Bright RK; Kennedy RC Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794 [TBL] [Abstract][Full Text] [Related]
33. Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells. Tevethia SS; Butel JS Intervirology; 1973; 2(3):200-5. PubMed ID: 4366480 [No Abstract] [Full Text] [Related]
34. Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts. Warnatz H; Krapf F J Immunol; 1976 Sep; 117(3):981-5. PubMed ID: 182884 [TBL] [Abstract][Full Text] [Related]
35. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Herberman RB; Nunn ME; Lavrin DH Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294 [TBL] [Abstract][Full Text] [Related]
36. Induction of SV40-tumour immunity by SV40-transformed cells in diffusion chambers. Stillström J Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):676-86. PubMed ID: 4372855 [No Abstract] [Full Text] [Related]
37. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors. Chapes SK; Gooding LR J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384 [TBL] [Abstract][Full Text] [Related]
38. Biology of SV40 transplantation antigen (TrAg). I. Demonstration of SV40 TrAg on glutaraldehyde-fixed SV40-infected African green monkey kidney cells. Tevethia MJ; Tevethia SS Virology; 1976 Feb; 69(2):474-89. PubMed ID: 176782 [No Abstract] [Full Text] [Related]
39. Cytolytic microassays and studies of SV40 tumor-specific transplantation antigen. Smith RW; Mora PT Virology; 1972 Oct; 50(1):233-46. PubMed ID: 4343110 [No Abstract] [Full Text] [Related]
40. Immunogenicity and immunosensitivity of SV40-transformed cells with different oncogenic potentials. Stillström J Int J Cancer; 1973 Sep; 12(2):493-501. PubMed ID: 4365094 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]